drugset / Trial / NCT05869643
A Clinical Trial of STP0404 in Adults With HIV-1 Infection
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the antiviral effect, safety, tolerability, and pharmacokinetics of STP0404 in adult participants living with Human Immunodeficiency Virus Type 1 (HIV-1) infection.
Timeline
- Start
- 2023-05-23
- Primary completion
- 2026-04-25
- Completion
- 2026-05-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pirmitegravir | Small molecule | — | Oral |